+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 146 Pages
  • April 2022
  • Region: Global
  • IMARC Group
  • ID: 5578085
UP TO OFF until Dec 31st 2022
The global biologics market reached a value of US$ 294 billion in 2021. Looking forward, the market is projected to reach US$ 501.9 billion by 2027, exhibiting a CAGR of 9.25% during 2022-2027. Keeping in mind the uncertainties of COVID-19, the analyst is continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



Biologics, also known as biological drugs, are disease-modifying antirheumatic drugs (DMARDs) made from living organisms or consist of components of living organisms. They include a wide variety of products, such as vaccines, blood, blood components, cells, genes, tissues, allergens, and recombinant proteins, derived from humans, animals, birds, insects, plants, and microorganisms. These products control the production of vital proteins, modify human hormones and cells, while producing substances to activate and suppress the immune system. They also change the manner of operation of natural biologic intracellular and cellular actions. In recent years, biologics have gained immense traction as they are essentially utilized to treat various diseases and conditions, including Crohn’s disease, ulcerative colitis, rheumatoid arthritis and other autoimmune diseases.

Biologics Market Trends


The global biologics market is primarily driven by the rising incidences and diagnosis of chronic diseases that have necessitated the availability of advanced diagnostics and treatment drugs. Biologics are genetically engineered to target a specific part of the immune system that fuels inflammation. Governments of different countries are also taking initiatives to promote the healthcare sector and ensure the availability of biologics with the onset of coronavirus disease (COVID-19). Furthermore, scientists and researchers are extensively investigating species and expression systems to enhance the productivity of biological products. Moreover, various pharmaceutical companies are undertaking research and development (R&D) activities to improve the efficacy of oral products for rheumatoid arthritis and Crohn’s diseases.

Key Market Segmentation


This report provides an analysis of the key trends in each sub-segment of the global biologics market, along with forecasts at the global, regional and country level from 2022-2027. The report has categorized the market based on source, product, disease and manufacturing.

Breakup by Source:

  • Microbial
  • Mammalian
  • Others

Breakup by Product:

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Antisense, RNAi and Molecular Therapy
  • Others

Breakup by Disease:

  • Oncology
  • Immunological Disorders
  • Cardiovascular Disorders
  • Hematological Disorders
  • Others

Breakup by Manufacturing:

  • Outsourced
  • In-House

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape


The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi.

Key Questions Answered in This Report

  • How has the global biologics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biologics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the source?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the disease?
  • What is the breakup of the market based on the manufacturing?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biologics market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Biologics Market

What is the estimated value of the Global Biologics Market?

The Global Biologics Market was estimated to be valued at $294 Billion in 2021.

What is the growth rate of the Global Biologics Market?

The growth rate of the Global Biologics Market is 9.3%, with an estimated value of $501.9 Billion by 2027.

What is the forecasted size of the Global Biologics Market?

The Global Biologics Market is estimated to be worth $501.9 Billion by 2027.

Who are the key companies in the Global Biologics Market?

Key companies in the Global Biologics Market include AbbVie Inc., Amgen Inc., AstraZeneca plc, F. Hoffmann, La Roche Ltd, GlaxoSmithKline plc, Johnson & Johnson, Merck KGaA and Pfizer Inc..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biologics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Source
6.1 Microbial
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Mammalian
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Monoclonal Antibodies
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Vaccines
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Recombinant Proteins
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Antisense, RNAi and Molecular Therapy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Disease
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Immunological Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Hematological Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Manufacturing
9.1 Outsourced
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 In-House
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 AbbVie Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Amgen Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 AstraZeneca plc
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche Ltd
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 SWOT Analysis
15.3.5 GlaxoSmithKline plc
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Johnson & Johnson
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Merck KGaA
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Novartis AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Pfizer Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Sanofi
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Biologics Market: Major Drivers and Challenges
Figure 2: Global: Biologics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Biologics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Biologics Market: Breakup by Source (in %), 2021
Figure 5: Global: Biologics Market: Breakup by Product (in %), 2021
Figure 6: Global: Biologics Market: Breakup by Disease (in %), 2021
Figure 7: Global: Biologics Market: Breakup by Manufacturing (in %), 2021
Figure 8: Global: Biologics Market: Breakup by Region (in %), 2021
Figure 9: Global: Biologics (Microbial) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Biologics (Microbial) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Biologics (Mammalian) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Biologics (Mammalian) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Biologics (Other Sources) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Biologics (Other Sources) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Biologics (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Biologics (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Biologics (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Biologics (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Biologics (Recombinant Proteins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Biologics (Recombinant Proteins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Biologics (Antisense, RNAi and Molecular Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Biologics (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Biologics (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Biologics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Biologics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Biologics (Immunological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Biologics (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Biologics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Biologics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Biologics (Hematological Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Biologics (Hematological Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Biologics (Other Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Biologics (Other Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Biologics (Outsourced) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Biologics (Outsourced) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Biologics (In-House) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Biologics (In-House) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: North America: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: North America: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: United States: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: United States: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Canada: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Canada: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Asia-Pacific: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Asia-Pacific: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: China: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: China: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Japan: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Japan: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: India: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: India: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: South Korea: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: South Korea: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Australia: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Australia: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Indonesia: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Indonesia: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Others: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Others: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Europe: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Europe: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Germany: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Germany: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: France: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: France: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: United Kingdom: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: United Kingdom: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Italy: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Italy: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Spain: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Spain: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Russia: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Russia: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Latin America: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Latin America: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Brazil: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Brazil: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Mexico: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Mexico: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Middle East and Africa: Biologics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Middle East and Africa: Biologics Market: Breakup by Country (in %), 2021
Figure 87: Middle East and Africa: Biologics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Global: Biologics Industry: SWOT Analysis
Figure 89: Global: Biologics Industry: Value Chain Analysis
Figure 90: Global: Biologics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Biologics Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Biologics Market Forecast: Breakup by Source (in Million US$), 2022-2027
Table 3: Global: Biologics Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Biologics Market Forecast: Breakup by Disease (in Million US$), 2022-2027
Table 5: Global: Biologics Market Forecast: Breakup by Manufacturing (in Million US$), 2022-2027
Table 6: Global: Biologics Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Biologics Market: Competitive Structure
Table 8: Global: Biologics Market: Key Players

Companies Mentioned

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi

Methodology

Loading
LOADING...